Home   »   About Us   »   Brian Kaspar, PhD

Our people

Brian Kaspar, PhD

Center for Gene Therapy, Nationwide Children's Hospital Ohio

Dr. Brian K. Kaspar is the founder and Chief Scientific Officer of Avexis, a gene therapy-based biotech company that was recently acquired by Novartis for $8.7 billion dollars. He has been a principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital and Associate Professor in the Department of Pediatrics and Department of Neuroscience at The Ohio State University College of Medicine. In 2013, Dr. Kaspar was named Fellow of the American Association for the Advancement of Science (AAAS). He has published more than 100 scientific articles. He received his PhD in molecular pathology from UC San Diego and did his postdoctoral work on neuroscience and gene therapy at the Salk Institute.  Dr. Kaspar founded two biotech companies (Avexis and Milo) working on gene therapy.

  • Michael Fossel, MD, PhD

    Founder, President

  • Peter Rayson

    Founder, Chief Executive Officer

  • Mark Hodges

    Chief Operating Officer (COO)

  • Russell Swerdlow, MD

    Director of Alzheimer's Diease Center. Professor of Neurology, University of Kansas

  • Suzanne Hendrix, PhD

    President, Pentara Corporation Salt Lake City, Utah

  • Mimoun Azzouz, PhD

    Chair Translational Neuroscience University of Sheffield, UK

  • Joseph Araujo, PhD

    CEO and President, InterVivo Solutions

  • Zaven Khachaturian, PhD

    Editor-in-Chief, Alzheimer’s & Dementia President PAD2020